deepseek

# Pilocarpine Eye Drops Enhance Results After Kahook Dual Blade Goniotomy ## Introduction Glaucoma is a leading cause of irreversible blindness worldwide, and surgical interventions like the Kahook Dual Blade (KDB) goniotomy have emerged as effective treatments to lower intraocular pressure (IOP). However, recent studies suggest that combining KDB with pilocarpine eye drops can further […]

# Sanoculis Secures CE Mark for Innovative Glaucoma Treatment Device ## Introduction In a significant milestone for ophthalmic innovation, **Sanoculis** has recently obtained the **CE Mark** for its groundbreaking glaucoma treatment device. This regulatory approval paves the way for the commercialization of their cutting-edge technology in **Europe**, offering new hope for patients suffering from this

# Top Glaucoma and Retina Trends at ASCRS & ASOA Annual Meetings The ASCRS & ASOA Annual Meetings are among the most anticipated events in ophthalmology, bringing together leading experts to discuss groundbreaking advancements in eye care. This year, the spotlight was on glaucoma and retina treatments, with innovative technologies, surgical techniques, and pharmaceutical developments

Breakthrough Glaucoma Monitoring Device Secures CIHR Commercialization Funding In a significant milestone for ophthalmology and medical technology, a groundbreaking glaucoma monitoring device has secured crucial funding from the Canadian Institutes of Health Research (CIHR) to advance its commercialization. This innovative device promises to revolutionize how glaucoma—a leading cause of irreversible blindness—is monitored and managed, offering

Does Glaucoma Run in Families? Hereditary Risks Explained Glaucoma is a leading cause of irreversible blindness worldwide, affecting millions of people. One of the most common questions patients ask is: does glaucoma run in families? The answer is yes—research shows that genetics play a significant role in glaucoma risk. Understanding the hereditary factors can help

# Preservative-Free Glaucoma Drops vs. MIGS: COPHy Insights Glaucoma management continues to evolve, with new treatment options offering improved efficacy and patient comfort. At the recent **Congress on Controversies in Ophthalmology (COPHy)**, experts debated the merits of **preservative-free glaucoma drops** versus **minimally invasive glaucoma surgery (MIGS)**. Both approaches aim to lower intraocular pressure (IOP) while

Transforming Indian Healthcare for a Brighter Future The Indian healthcare system is at a pivotal moment. With a growing population, increasing life expectancy, and rising healthcare demands, the need for transformation has never been more urgent. From digital innovations to policy reforms, India is taking bold steps to ensure a healthier future for its citizens.

Open Angle Glaucoma Clinical Trials and FDA Approvals 2025 Analysis Open-angle glaucoma (OAG) remains one of the leading causes of irreversible blindness worldwide. As research advances, 2025 is poised to be a pivotal year for clinical trials and FDA approvals in this space. This article delves into the latest developments, emerging therapies, and regulatory milestones

Sight Sciences Announces Q1 2025 Financial Results on May 8 Sight Sciences, Inc., a leading innovator in ophthalmology and optometry, has announced that it will release its Q1 2025 financial results on May 8, 2025. This eagerly anticipated update will provide insights into the company’s performance, growth trajectory, and strategic initiatives in the first quarter

NESC Launches Innovative Eye Healthcare Software in Liberia In a groundbreaking move to revolutionize eye healthcare in Liberia, the National Eye Care Services (NESC) has introduced an innovative software solution designed to enhance diagnosis, treatment, and patient management. This cutting-edge technology aims to address the growing need for accessible and efficient eye care services across